Effect of Lysine at C-terminus of the Dmt-Tic Opioid Pharmacophore

Overview

Journal J Med Chem

Publisher American Chemical Society

Specialty Chemistry

Date 2006 Sep 1

PMID 16942034

Citations 16

Authors

Gianfranco Balboni

Valentina Onnis

Cenzo Congiu

Margherita Zotti

Yusuke Sasaki

Akihiro Ambo

Sharon D Bryant

Yunden Jinsmaa

Lawrence H Lazarus

Claudio Trapella

Severo Salvadori

Affiliations

Soon will be listed here.

Abstract

Substitution of Gly with side-chain-protected or unprotected Lys in lead compounds containing the opioid pharmacophore Dmt-Tic [H-Dmt-Tic-Gly-NH-CH(2)-Ph, mu agonist/delta antagonist; H-Dmt-Tic-Gly-NH-Ph, mu agonist/delta agonist; and H-Dmt-Tic-NH-CH(2)-Bid, delta agonist (Bid = 1H-benzimidazole-2-yl)] yielded a new series of compounds endowed with distinct pharmacological activities. Compounds (1-10) included high delta- (Ki(delta) = 0.068-0.64 nM) and mu-opioid affinities (Ki(mu) = 0.13-5.50 nM), with a bioactivity that ranged from mu-opioid agonism {10, H-Dmt-Tic-NH-CH[(CH2)4-NH2]-Bid (IC50 GPI = 39.7 nM)} to a selective mu-opioid antagonist [3, H-Dmt-Tic-Lys-NH-CH2-Ph (pA2(mu) = 7.96)] and a selective delta-opioid antagonist [5, H-Dmt-Tic-Lys(Ac)-NH-Ph (pA2(delta) = 12.0)]. The presence of a Lys linker provides new lead compounds in the formation of opioid peptidomimetics containing the Dmt-Tic pharmacophore with distinct agonist and/or antagonist properties.

Citing Articles

Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells.

Cai B, El Daibani A, Bai Y, Che T, Krusemark C JACS Au. 2023; 3(4):1076-1088.

PMID: 37124302 PMC: 10131204. DOI: 10.1021/jacsau.2c00674.

Selection of DNA-Encoded Libraries to Protein Targets within and on Living Cells.

Cai B, Kim D, Akhand S, Sun Y, Cassell R, Alpsoy A J Am Chem Soc. 2019; 141(43):17057-17061.

PMID: 31613623 PMC: 7057806. DOI: 10.1021/jacs.9b08085.

A DFT and semiempirical model-based study of opioid receptor affinity and selectivity in a group of molecules with a morphine structural core.

Bruna-Larenas T, Gomez-Jeria J Int J Med Chem. 2014; 2012:682495.

PMID: 25379287 PMC: 4207423. DOI: 10.1155/2012/682495.

Engineering endomorphin drugs: state of the art.

Lazarus L, Okada Y Expert Opin Ther Pat. 2012; 22(1):1-14.

PMID: 22214283 PMC: 3253703. DOI: 10.1517/13543776.2012.646261.

Current research on opioid receptor function.

Feng Y, He X, Yang Y, Chao D, Lazarus L, Xia Y Curr Drug Targets. 2011; 13(2):230-46.

PMID: 22204322 PMC: 3371376. DOI: 10.2174/138945012799201612.

References

Salvadori S, Guerrini R, Balboni G, Bianchi C, Bryant S, Cooper P . Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism. J Med Chem. 1999; 42(24):5010-9. DOI: 10.1021/jm990165m. View

Vazquez M, Blanco J, Salvadori S, Trapella C, Argazzi R, Bryant S . 6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides. J Med Chem. 2006; 49(12):3653-8. PMC: 1994907. DOI: 10.1021/jm060343t. View

Balboni G, Salvadori S, Guerrini R, Bianchi C, Santagada V, Calliendo G . Opioid pseudopeptides containing heteroaromatic or heteroaliphatic nuclei. Peptides. 2000; 21(11):1663-71. DOI: 10.1016/s0196-9781(00)00315-6. View

Hall F, Sora I, Uhl G . Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology (Berl). 2001; 154(1):43-9. DOI: 10.1007/s002130000622. View

Krystal J, Cramer J, KROL W, Kirk G, Rosenheck R . Naltrexone in the treatment of alcohol dependence. N Engl J Med. 2001; 345(24):1734-9. DOI: 10.1056/NEJMoa011127. View

Balboni G, Guerrini R, Salvadori S, Bianchi C, Rizzi D, Bryant S . Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties. J Med Chem. 2002; 45(3):713-20. DOI: 10.1021/jm010449i. View

Zhang J, Gibney G, Zhao P, Xia Y . Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol. 2002; 282(6):C1225-34. DOI: 10.1152/ajpcell.00226.2001. View

Balboni G, Salvadori S, Guerrini R, Negri L, Giannini E, Jinsmaa Y . Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore. J Med Chem. 2002; 45(25):5556-63. DOI: 10.1021/jm020336e. View

Sasaki Y, Sasaki A, Niizuma H, Goto H, Ambo A . Endomorphin 2 analogues containing Dmp residue as an aromatic amino acid surrogate with high mu-opioid receptor affinity and selectivity. Bioorg Med Chem. 2003; 11(5):675-8. DOI: 10.1016/s0968-0896(02)00601-6. View

10.

Page D, Nguyen N, Bernard S, Coupal M, Gosselin M, Lepage J . New scaffolds in the development of mu opioid-receptor ligands. Bioorg Med Chem Lett. 2003; 13(9):1585-9. DOI: 10.1016/s0960-894x(03)00194-x. View

11.

Bryant S, Jinsmaa Y, Salvadori S, Okada Y, Lazarus L . Dmt and opioid peptides: a potent alliance. Biopolymers. 2003; 71(2):86-102. DOI: 10.1002/bip.10399. View

12.

Oslin D, Berrettini W, Kranzler H, Pettinati H, Gelernter J, Volpicelli J . A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology. 2003; 28(8):1546-52. DOI: 10.1038/sj.npp.1300219. View

13.

Balboni G, Salvadori S, Guerrini R, Negri L, Giannini E, Bryant S . Synthesis and opioid activity of N,N-dimethyl-Dmt-Tic-NH-CH(R)-R' analogues: acquisition of potent delta antagonism. Bioorg Med Chem. 2003; 11(24):5435-41. DOI: 10.1016/j.bmc.2003.09.039. View

14.

Peart J, Gross G . Exogenous activation of delta- and kappa-opioid receptors affords cardioprotection in isolated murine heart. Basic Res Cardiol. 2003; 99(1):29-37. DOI: 10.1007/s00395-003-0430-y. View

15.

Ananthan S, Khare N, Saini S, Seitz L, Bartlett J, Davis P . Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone]. J Med Chem. 2004; 47(6):1400-12. DOI: 10.1021/jm030311v. View

16.

Oswald L, Wand G . Opioids and alcoholism. Physiol Behav. 2004; 81(2):339-58. DOI: 10.1016/j.physbeh.2004.02.008. View

17.

Balboni G, Salvadori S, Guerrini R, Negri L, Giannini E, Bryant S . Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism. J Med Chem. 2004; 47(16):4066-71. DOI: 10.1021/jm040033f. View

18.

Saitoh A, Kimura Y, Suzuki T, Kawai K, Nagase H, Kamei J . Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J Pharmacol Sci. 2004; 95(3):374-80. DOI: 10.1254/jphs.fpj04014x. View

19.

Borlongan C, Wang Y, Su T . Delta opioid peptide (D-Ala 2, D-Leu 5) enkephalin: linking hibernation and neuroprotection. Front Biosci. 2004; 9:3392-8. DOI: 10.2741/1490. View

20.

Cheng Y, Prusoff W . Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973; 22(23):3099-108. DOI: 10.1016/0006-2952(73)90196-2. View